Shingen Misaka - Concepedia

Author

Shingen Misaka

University of Shizuoka ORCID

Also Known As

S MISAKA, S Misaka, S. Misaka, SHINGEN MISAKA, Shingen Misaka

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Shizuoka Fukushima Medical University Hamamatsu University School of Medicine Friedrich-Alexander-Universität Erlangen-Nürnberg Centro Cardiologico Monzino

About

Shingen Misaka is an author at University of Shizuoka specializing in pharmacology, medicine, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	437
2	Biochemistry	7	7	279
3	Natural Sciences	4	4	100
4	Allergy	2	2	26
5	Cellular Physiology	1	1	44

Shingen Misaka

Publications

975

Citations

H-Index

Page 1

	Year	Citations
Green Tea Ingestion Greatly Reduces Plasma Concentrations of Nadolol in Healthy Subjects Shingen Misaka, Junichi Yatabe, Fabian Müller, Clinical Pharmacology & Therapeutics	2014	143
Effects of Green Tea Catechins on Cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A Activities in Human Liver and Intestinal Microsomes Shingen Misaka, Keisuke Kawabe, Satomi Onoue, Drug Metabolism and Pharmacokinetics	2012	105
Inhibitory Effects of Green Tea and (–)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein J. Knop, Shingen Misaka, Katrin Singer, PLoS ONE Food ChemistryInhibitory EffectsBiochemistryMedicineBioanalysis	2015	90
Role of (−)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers Osamu Abe, Tomoyuki Ono, Hideyuki Sato, European Journal of Clinical Pharmacology Pharmacological StudyBiochemistryHealthy VolunteersPharmacologyHerb-drug Interaction	2018	60
The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3 Shingen Misaka, J. Knop, Katrin Singer, Molecular Pharmaceutics GlycobiologyMolecular BiologyCellular PharmacologyNonmetabolized β-Blocker NadololExperimental Pharmacology	2015	44
Benzbromarone Pharmacokinetics and Pharmacodynamics in Différent Cytochrome P450 2C9 Genotypes Shinya Uchida, Kayoko Shimada, Shingen Misaka, Drug Metabolism and Pharmacokinetics	2010	40
Pharmacokinetic and Pharmacodynamic Interaction of Nadolol With Itraconazole, Rifampicin and Grapefruit Juice in Healthy Volunteers Shingen Misaka, Nozomu Miyazaki, Midori Yatabe, The Journal of Clinical Pharmacology	2013	35
Green Tea Extract Affects the Cytochrome P450 3A Activity and Pharmacokinetics of Simvastatin in Rats Shingen Misaka, Keisuke Kawabe, Satomi Onoue, Drug Metabolism and Pharmacokinetics	2013	35
Inhalable powder formulation of a stabilized vasoactive intestinal peptide (VIP) derivative: Anti-inflammatory effect in experimental asthmatic rats Shingen Misaka, Yosuke Aoki, Shin-ichiro Karaki, Peptides AsthmaInhalable Powder FormulationInflammationAnti-inflammatoryMedicine	2009	35
Effects of green tea extract and (−)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats Shingen Misaka, Nozomu Miyazaki, T Fukushima, Phytomedicine Medicinal ChemistryFood Bioactive CompoundPharmacological StudyBiochemistryGreen Tea Extract	2013	34

Page 1